ZnII/pyridyloxime complexes as potential reactivators of OP-inhibited acetylcholinesterase: In vitro and docking simulation studies

Konidaris, Konstantis F.; Δάλκας, Γεώργιος; Katsoulakou, Eugenia; Pairas, George; Raptopoulou, Catherine P.; Lamari, Fotini N.; Spyroulias, Georgios A.; Manessi‐Zoupa, Evy

doi:10.1016/j.jinorgbio.2013.12.011

Cited by 2 publications

References 35 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

SAR study to find optimal cholinesterase reactivator against organophosphorous nerve agents and pesticides

et al. 2016

View full text Add to dashboard Cite

Irreversible inhibition of acetylcholinesterase (AChE) by organophosphates leads to many failures in living organism and ultimately in death. Organophosphorus compounds developed as nerve agents such as tabun, sarin, soman, VX and others belong to the most toxic chemical warfare agents and are one of the biggest threats to the modern civilization. Moreover, misuse of nerve agents together with organophosphorus pesticides (e.g. malathion, paraoxon, chlorpyrifos, etc.) which are annually implicated in millions of intoxications and hundreds of thousand deaths reminds us of insufficient protection against these compounds. Basic treatments for these intoxications are based on immediate administration of atropine and acetylcholinesterase reactivators which are currently represented by mono- or bis-pyridinium aldoximes. However, these antidotes are not sufficient to ensure 100 % treatment efficacy even they are administered immediately after intoxication, and in general, they possess several drawbacks. Herein, we have reviewed new efforts leading to the development of novel reactivators and proposition of new promising strategies to design novel and effective antidotes. Structure-activity relationships and biological activities of recently proposed acetylcholinesterase reactivators are discussed and summarized. Among further modifications of known oximes, the main attention has been paid to dual binding site ligands of AChE as the current mainstream strategy. We have also discussed new chemical entities as potential replacement of oxime functional group.

show abstract